NCT03940885

Brief Summary

Abdominoplasty is one of the most popular body-contouring procedures. Patients that undergo body-contouring abdominoplasty usually have important analgesic requirements. Given the substantial incision and soft-tissue undermining associated with this procedure, postoperative pain is a concern for patients and surgeons. Previous studies have typically incorporated multiple nerve blocks to improve analgesia after abdominoplasty. Different anesthetic techniques have been developed to overcome this problem such as Epidural anesthesia, Transversus abdominis plane block either open technique or ultrasound-guided, Paravertebral block and Erector Spinea plane block. Improving postoperative pain control in this kind of surgery leads to earlier mobilization, shortened hospital stay, reduced hospital costs, and increased patient satisfaction. The ultrasound-guided erector spinae plane (ESP) block is a recent block described for various surgeries for postoperative analgesia. It is reported that it have an analgesic effect on somatic and visceral pain by affecting the ventral rami and rami communicantes that include sympathetic nerve fibres, as LA spreads through the paravertebral space. When performed bilaterally it has been reported to be as effective as thoracic epidural analgesia. The transversus abdominis plane (TAP) block is a technique of locoregional anesthesia that blocks the sensorial afferent nerves localized between the transversus abdominis muscle and the internal oblique muscle. In this study, the analgesic efficacy and duration of ultrasound (US) guided Erector spinea plane block and Transversus abdominis plane block when Lidocaine HCL is added as an adjuvant to bupivacaine will be compared.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
69

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 6, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 7, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

September 25, 2020

Status Verified

September 1, 2020

Enrollment Period

2 years

First QC Date

May 6, 2019

Last Update Submit

September 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total opioid consumption

    cumulative consumption of rescue opioids during the first postoperative day

    For 24 hours after performing block

Secondary Outcomes (7)

  • Duration of analgesia

    for 24 hours after performing block

  • Postoperative visual analogue score

    for 24 hours after performing block

  • Cortisol level

    For one hour after performing block

  • Heart rate

    For 24 hours after surgery

  • Mean arterial blood pressure

    For 24 hours after surgery

  • +2 more secondary outcomes

Study Arms (3)

Erector spinea plane block group

ACTIVE COMPARATOR

this group is planned for ultrasound-guided Transversus abdominis plane block

Procedure: Erector spinea plane block group

Transversus abdominis plane block

ACTIVE COMPARATOR

this group is planned for ultrasound-guided Transversus abdominis plane block

Procedure: Transversus abdominis plane block

Control group

PLACEBO COMPARATOR

standard general anesthesia

Procedure: Control group

Interventions

Which will receive ultrasound-guided erector spinea plane block bilaterally and the local anesthetic injected will be total volume 25 ml on each side consisting of 15ml of 0.5% plus 5 ml 2% lidocaine HCL plus 5 ml saline

Erector spinea plane block group

Which will receive ultrasound-guided Transversus Abdominis plane block bilaterally and the local anesthetic used will be total volume 25 ml on each side consisting of 15ml of 0.5% plus 5 ml 2% lidocaine HCL plus 5 ml saline

Transversus abdominis plane block
Control groupPROCEDURE

this group will receive only standard general anesthesia

Control group

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American society of anesthesiologist grade I-II

You may not qualify if:

  • Patient refusal.
  • Local skin infection and sepsis at the site of the block.
  • Allergy to local anesthetic used.
  • Hematological diseases
  • Bleeding disease.
  • Coagulation abnormality.
  • Psychiatric disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hanaa M Elbendary

Al Mansurah, DK, 050, Egypt

RECRUITING

Related Publications (1)

  • Mankikar MG, Sardesai SP, Ghodki PS. Ultrasound-guided transversus abdominis plane block for post-operative analgesia in patients undergoing caesarean section. Indian J Anaesth. 2016 Apr;60(4):253-7. doi: 10.4103/0019-5049.179451.

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Hanaa M Elbendary, MD

    Anesthesia Department, Faculty of Medicine, Mansoura University

    STUDY CHAIR

Central Study Contacts

Hanaa M Elbendary, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: single-blind study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2019

First Posted

May 7, 2019

Study Start

April 1, 2019

Primary Completion

April 1, 2021

Study Completion

June 1, 2021

Last Updated

September 25, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will share

Following completing recruiting and opening the dataset, the investigators would upload the raw data and results to the registry

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The data will become available following completing the study for life-long
Access Criteria
The data will be accessible to the investigators and PRS administrators with hiding the identifiers for the patients

Locations